The association between maternal smoking and preterm birth (PTB) has been known for more than 50 years but the effect of passive smoking is controversial. This retrospective cohort study in Bristol, United Kingdom, examines the effect of environmental tobacco smoke exposure (ETSE) on gestational age at delivery, birth weight, PTB, and being small-for-gestational age (SGA). Environmental tobacco smoke exposure was defined by either self-report or exhaled carbon monoxide (eCO) levels, and exposed women were compared with unexposed controls. Two models were used: The first included all women with adjustment for maternal smoking, and the second considered nonsmokers alone. Both models were further adjusted for maternal age, body mass index, parity, ethnicity, employment status, socioeconomic position, asthma, preeclampsia, and offspring sex. Logistic regression and likelihood ratio tests were used to test for any association between exposure and the binary outcomes (PTB and SGA), while linear regression and F tests were used to test for associations between exposure and the continuous outcomes. There were 13 359 deliveries in 2012 to 2014, with complete data for 5066 and 4793 women in the self-reported and eCO-measured exposure groups, respectively. Self-reported exposure was associated with earlier delivery (À0.19 weeks; 95% confidence interval [CI]: À0.32 to À0.05) and reduced birth weight (À56 g, 95% CI: À97 to À16 g) but no increase in the risk of PTB or SGA. There was no evidence for an association between eCO-measured exposure and any of the outcome measures. This information is important when advising women and their families and adds further support to continued public health efforts to reduce exposure to tobacco smoke.
Introduction
The association between maternal smoking, reduced birth weight, and preterm birth (PTB) has been known for more than 50 years. 1 Maternal smoking increases the risk of PTB by around 27%, 2 and a dose-response relationship has been described in which heavier smoking is associated with a higher risk. 2, 3 Proposed mechanisms for the adverse perinatal outcomes include reduced fetal oxygenation secondary to increased carbon monoxide and nicotine-induced vasoconstriction. 4 Previous studies have demonstrated the deleterious effect of active smoking during pregnancy, but the extent of the effects of passive smoking is still uncertain. [5] [6] [7] Complications related to prematurity account for more than 1 million deaths each year worldwide. 8 The survivors often face severe morbidity into childhood and beyond. 9 There are serious negative psychosocial and emotional effects on the family and important resource implications for society. 9 Preterm birth is the leading cause of perinatal mortality and morbidity and its prevention is a global priority. 8 Cigarette smoking during pregnancy is one of the few preventable causes of adverse pregnancy outcomes, and focusing on smoking cessation should be a way to reduce the incidence of PTB. Despite a 20% to 40% reduction in smoking rates in pregnancy over the past 30 years, 10 between 11% and 13% of women continue to smoke throughout their pregnancy. [10] [11] [12] [13] The introduction of antismoking legislation has reduced PTB birth rates by around 10%. 14 This is most likely mediated by a reduction in the number of women smoking during their pregnancies, but there is emerging evidence that environmental exposure to tobacco smoke, known as passive smoking, may also affect PTB rates. It has been estimated that 11% to 50% of nonsmoking pregnant women are exposed to environmental tobacco smoke, 5, 7, [15] [16] [17] and this exposure has been associated with reduced birth weight. 5 Currently, there is conflicting evidence on the effects of environmental tobacco smoke exposure (ETSE) on PTB. Several meta-analyses [5] [6] [7] have failed to show an association between the 2, but existing studies are limited by residual confounding factors and the difficulties of accurately determining exposure. In this article, we have addressed these limitations by designing a study with correction for confounding factors and by evaluating the use of a recently introduced routine measure of exposure in the first trimester, namely exhaled carbon monoxide (eCO) levels. The levels of eCO have been shown to correlate with the number of cigarettes smoked 18 and are affected by ETSE. [19] [20] [21] The objective of this study was to investigate whether ETSE is an independent risk factor for shortened gestation and PTB, using both self-report and eCO, as an objective measure of exposure, in a large obstetric population.
Methods

Study Design and Sample
We performed a retrospective cohort study of all women with singleton pregnancies of at least 23 weeks of gestation delivering at the University Hospitals Bristol NHS Foundation Trust between April 2012 and September 2014. Women were identified using the computerized Maternity Medway Database, which records details of all women delivering within the Trust. At the first antenatal appointment, usually before 12 weeks of gestation, the community midwife enters relevant obstetric and medical history into the database including the woman's smoking status, eCO level, her partner's smoking status, and the presence of any other smokers in the household. Information about the birth is added to this computerized record immediately after delivery.
Multiple births often have obstetric complications that result in a higher incidence of PTB. The analysis was restricted to singleton births. Due to the referral nature of our hospital, women were referred from across the region for a variety of serious pregnancy complications. These ''out-of-area'' women had a higher background risk of PTB because of these complications and were excluded from the study population in order to improve the representativeness of the study. Ethical approval for this study was obtained from the University of Bristol Research Ethics Committee (ref. 2120).
Outcomes
The primary outcomes for this study were gestational age at delivery and PTB (<37 weeks' gestation). Gestational age at delivery (in weeks) was calculated from antenatal ultrasound scan (USS; usually during the first trimester) or last menstrual period where USS had not taken place. Secondary outcomes included birth weight and small-for-gestational age (defined as less than the population gestation-specific 10th centile).
Exposures
Exposure to environmental tobacco smoke was assessed in 2 ways. First, by self-report, a binary variable was created where pregnant women were coded as exposed if they reported that either their partner or another member of the household smoked. We refer to this as ''household smoking.'' Second, by objective measurement, eCO was measured at the first antenatal appointment (usually during the first trimester) using a hand-held Bedfont piCOþ Smokerlyzer (Bedfont Scientific, United Kingdom, http://www.bedfont.com). Women were asked to inhale and hold their breath for 15 seconds before exhaling into the analyzer. The first reading was recorded.
Potential Confounders
We assessed several potential confounders, identified from the literature and univariate analyses, in logistic regression models. These include maternal smoking, maternal age at delivery, body mass index, BMI ¼ weight (kg)/height (m) 2 , fetal sex, parity, ethnicity, a diagnosis of asthma 22 or preeclampsia, 23 employment status, and socioeconomic position as determined by postcode-linked Index of Multiple Deprivation scores which have been shown to be a useful marker of socioeconomic status. 24 Age at delivery, fetal sex, and any current pregnancy diagnosis of preeclampsia were recorded at delivery, while self-reported maternal smoking status and the other variables were recorded at the first antenatal appointment, usually in the first trimester.
Analysis
A range of summary statistics was used to describe the women in the study. We used z-tests and chi-square tests to compare the characteristics of women in the analysis samples with those eligible but excluded from the analysis due to a missing value on one or more of the covariables.
Analysis Strategy and Models
To check the external validity of the hospital database, we first examined the associations between self-reported maternal smoking and each outcome to ensure they were comparable to previously reported estimates. Next, we considered the effect of ETSE. Both self-reported household smoking and measured eCO were used as indicators of ETSE. Two analysis models were used: The first included all women and adjusted for maternal smoking. The second considered only the nonsmoking women. Both models were adjusted for maternal age, BMI, parity, ethnicity, employment status, socioeconomic position, asthma, preeclampsia, and offspring sex.
These models were fitted for each of the outcomes. Logistic regression was used for binary outcomes (PTB) and small for gestational age (SGA) and linear regression for continuous outcomes (gestational age at delivery and birth weight). Likelihood ratio tests (for logistic regression models) and F tests (for linear regression models) were used to test for any association between the exposures and outcomes.
The eCO cutoff value at which exposure to environmental tobacco smoke can be determined is uncertain. Several authors have suggested cutoff values between 2 and 4 ppm, 25, 26, 27 when distinguishing smokers from nonsmokers, a value of 2 ppm giving a sensitivity of 86% and specificity of 90%. 25 To examine whether our results were robust to the choice of cutoff and way in which eCO was classified, we repeated the analysis using 4 and 6 ppm as cutoffs instead of 2 ppm. We also modelled the relationship between eCO and the outcomes as a linear continuous variable and as a shape-free cubic spline to see whether there was a particular form of relationship that was missed by our main parameterization. STATA version 13.1 was used for all analyses.
Results
Sample Description
We documented 13 359 eligible deliveries at gestations greater than 23 weeks, after excluding multiple pregnancies (450 deliveries) and one case with no gestational age at delivery recorded ( Figure 1 ). For the analyses involving self-reported exposure, there were 5066 (38%) deliveries with complete data, and for the analyses involving objective exposure (eCO), there were 4793 (36%) cases with complete data.
A comparison of the characteristics of the complete cases (see Figure 1 ) and those eligible but with at least 1 piece of missing data is shown in Table 1 . The median age was 30 years, and the majority of women were white and employed. Approximately 42% of all women reported the presence of a smoker in their household and the median eCO was 1 ppm. The proportion of exposed nonsmokers increased from 17.8%, when considering partner smoking alone, to 28.0% when considering all household members. In the analysis group, the incidence of PTB was 6.3%. This rate was slightly lower among those with missing information. Paradoxically, those missing some information on covariables, and therefore not included in the analysis, were more likely to report living with a smoker. Women reporting as nonsmokers were more likely to have information on household smoking and eCO readings missing. The gestational age at booking was not significantly different between the exposed and unexposed women.
Association of Exposures and Outcomes With Confounders
Generally, women from more deprived postal areas and women unemployed or unfit to work were more likely to live with smokers, have higher eCO readings, and a higher risk of PTB and SGA baby. The distributions of household smoking, eCO, and outcomes were also patterned to a varying extent by the other potential confounders (maternal age, parity, BMI, ethnicity, and asthma; data not shown). Smoking was associated with a lower risk of preeclampsia (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.50-0.93).
Maternal Smoking: Prevalence and Association With Perinatal Outcomes
Of the 13 094 women whose smoking status was known, 2946 women reported smoking in the early part of their pregnancy (22.5%). Of these smokers, 1043 (35.4%) stopped before their first antenatal appointment, leaving 14.5% of women reporting as smokers at the first antenatal appointment.
After adjustment for maternal age, BMI, ethnicity, parity, employment status, socioeconomic status, fetal sex, paternal smoking, preeclampsia and asthma, maternal smoking was associated with a more than 2-fold increased risk of PTB (OR: 2.16; 95% CI 1.56-2.99, P < .001), a reduction in gestational length of 0.6 weeks (95% CI À0.7 to À0.4, P < .001), a mean reduction in birth weight of 350 g (CI À399 to À302, P < .001), and a 3 times greater risk of SGA (OR 3.06, 95% CI 2.33-4.03, P < .001) when compared to nonsmoking women. Compared to eCO readings of zero, eCO values ! 2 ppm were associated with an increased risk of PTB (OR 1.63, 95% CI 1.14-2.32, P ¼ .017) and SGA (OR 1.76, 95% CI 1.34-2.32, P < .001), a shorter gestation (À0.29 weeks; 95% CI À0.45 to À0.12, P ¼ .003) and a mean reduction in birth weight (À166 g; 95% CI À214 to À118 g, P < .001).
There was no evidence that women who stopped smoking between conception and their first antenatal appointment were at any additional risk of PTB, reduced gestational length, lower birth weight babies, or SGA when compared to nonsmokers.
ETSE and Perinatal Outcomes
Self-reported exposure. After adjustment for maternal smoking, women who reported themselves as exposed to ETS gave birth to their babies earlier. These associations persisted when considering only the nonsmoking women and after adjustment for confounding factors including preeclampsia ( Table 2) ; babies were born on average 0.19 weeks earlier (95% CI: À0.32 to À0.05) among nonsmoking women that reported a smoker in the house compared with nonsmokers with no household exposure.
We found a crude association between self-reported exposure to household smoking and PTB: The odds of PTB were 31% higher (95% CI: 0-72) among women living with smokers (after adjusting for maternal smoking), but this weakened to 22% (95% CI: À9 to 62) after adjustment for other potential confounders, providing no evidence of an independent association between self-reported ETSE and PTB (Table 3) .
There was strong evidence that babies born to mothers who lived with smokers had lower birth weights when compared to the babies born to unexposed mothers, after adjustment for maternal smoking and other confounders ( Table 4 ). This association remained consistent when considering only the nonsmoking mothers. Babies born to nonsmoking mothers who reported a smoker in their household were on average 56 g lighter (95% CI: À97 to À16 g). Self-reported ETSE was not associated with a change in the risk of SGA (Table 5 ).
Exhaled Carbon Monoxide Measurement as an Objective Measure of ETSE
When an eCO level greater than 2 ppm was used to define ETSE, there was no association between ETSE and gestational age at delivery, PTB, birth weight, or risk of SGA. This was the case when considering all women with adjustment for maternal smoking and when considering nonsmoking women alone.
Sensitivity Analysis
There is some controversy about the best value for eCO to define ETSE. 26, 27 When replacing !2 ppm with !4 ppm as a cutoff category for eCO, as suggested elsewhere, 26, 27 there was some weak evidence of an association between PTB and eCO-measured ETSE. For example, the OR for PTB adjusting for maternal smoking and confounders was 1.7 (95% CI: 1.04-2.8) in all women and 2.04 (95% CI: 0.9-4.64) in nonsmoking women. When !6 ppm was used as the cutoff for eCO-determined ETSE, the associations were stronger than for 2 ppm although there was no statistical evidence of an association with PTB. The results for SGA were fairly consistent regardless of choice of cutoff. For gestational age and birth weight, the associations were generally stronger when a higher eCO cutoff was used, making the results more similar to those 
Discussion
This is the first large cohort study to consider the effect of ETSE on PTB and gestational age at delivery using eCO as an objective measure of exposure. When smoking women were included in the analysis, elevated eCO levels were strongly associated with PTB, reduced gestational age at delivery, reduced birth weight, and increased risk of SGA. However, when the smokers were excluded or controlled for, elevated eCO readings were not significantly associated with any of the outcome measures. Self-reported ETSE was strongly associated with reduced gestational age at delivery and reduced birth weight but not with an increased risk of SGA or PTB.
Strengths and Limitations
This population-based study includes over 13 000 women of which more than a third were nonsmoking women with complete information on their environmental smoke exposure. The proportion of women exposed to environmental tobacco smoke varies in the literature depending upon how exposure is defined, the country studied, and the time of the study, because smoking prevalence has changed over recent decades. 10 Traditional family structures and living circumstances have changed considerably over the last few decades. While ETSE from work is now less common because of antismoking legislation, women are still at risk of ETSE if their partner or any member of the household smokes. Our study is strengthened by our use of a combined measure of exposure; simply considering the smoking status of a woman's partner, as many studies have done, may be inadequate in assessing her exposure. We have shown that the proportion of exposed nonsmokers increased from 17.8%, when considering partner smoking alone, to 28.0% when considering all household members. Self-reported smoking behavior has generally been found to be reliable when it has been validated with biochemical measures. 28 However, some evidence suggests self-reporting of both active and passive smoking may be less reliable in pregnancy, [29] [30] [31] perhaps because of the additional social stigma associated with smoking in pregnancy and the desire to make a good impression to health care professionals. The use of an objective measure is a strength of our study. Many objective measures of exposure have been used previously; nicotine and cotinine, the major metabolite of nicotine, 32 can be measured in serum, 30 saliva 33 hair, 31 meconium, 34 and urine. 27 Measuring eCO levels has the advantage of being cheap, noninvasive, and giving immediate results; eCO levels correlate well with other biochemical measures of exposure. 18, 20 While a number of studies have considered the role of eCO in determining a woman's smoking status, 18, 25, 27, 35, 36 none have used eCO to define exposure when considering the effect of ETSE on gestational age at delivery. A cutoff of 2 ppm was chosen after recent data suggested specificity of 90% and sensitivity of 86% at this level when distinguishing between smokers and nonsmokers. 25 Since asthma 22 and preeclampsia 37 have been reported to affect eCO levels, we ensured these confounders were included when adjusting the models.
While most studies have adjusted for possible confounding factors such as maternal age, parity, race, and socioeconomic status, 2 adjustments for preeclampsia have not been made previously. 5 Preeclampsia is a common reason for elective PTB. Active maternal smoking appears to decrease the risk of preeclampsia by approximately 30%. 23, 38 A similar trend for passive smoking has been reported. 39 This complex interplay requires that preeclampsia is considered when determining the effect of smoking, active or passive, on PTB rates, in order to avoid under-estimating the true effect of smoking. The correction for preeclampsia as a confounding factor is another strength of our study and may explain the greater risk of PTB for smokers that we observed (OR 2.16) compared to the more conservative estimate in a recent meta-analysis (OR 1.27). 2 The prospective way in which exposure information was collected reduces the risk of reporting bias. However, the study is restricted by the large proportion of missing data, especially exposure information. Although women's smoking status was well recorded (98%), their partner's status and the presence of other smokers in the household were less frequently recorded (54% and 49% of cases respectively). Despite national recommendations in the United Kingdom that all women, regardless of their smoking status, have eCO readings taken at their first antenatal appointment, 40 readings were only recorded in 42% cases. Women with incomplete data were excluded from the analyses (Figure 1 ) possibly introducing selection bias, although no consistent differences in associations were observed in this ''missing data'' cohort and the analysis group, and there was no systematic reason for data not being available.
Our objective measure of ETSE has its limitations: CO has a short half-life (around 1-4 hours) 36 and the time since exposure The association observed between PTB and higher eCO levels (>4 ppm) could represent more heavily exposed nonsmokers or perhaps smokers reporting as nonsmokers. Seasonal variation in birth patterns including the outcomes considered here has been described, 41 although few studies on perinatal outcomes adjust for this. Additionally, seasonal variation in ETSE is possible, with women potentially more exposed at times of the year with poorer weather. Our data had insufficient information to make seasonal adjustments but we recommend further research on the effect of ETS consider these issues where possible.
In this study, smoking rates in pregnancy (14.5%) were similar to those previously reported in the literature (11%-16%) 10, 12, 16 ; interestingly the proportion of nonsmoking women reporting exposure to ETS (28%) was more than 2-fold higher than recent reports for other United Kingdom and European populations (11%-13%) 7, 16 and probably reflects the inclusion of women living with smokers as well as those whose partners smoke (most studies only consider exposure from partner smoking). It is also possible that the addition of an objective measure of exposure (eCO reading) may encourage disclosure or even some smokers to self-report as exposed nonsmokers.
Biochemical measures of exposure may alleviate some of the problems associated with inaccurate self-reporting. However, the use of biochemical measures is not without problems; differentiating between light active smokers and heavily exposed passive smokers remains difficult, 42 and adjustment for maternal smoking requires reliance on maternal reports of smoking behavior. While knowing the effects of lower levels of exposure is important (whether that is from environmental or lighter active smoking), the success of programs aimed at changing smoking behavior will depend upon knowing to whom interventions should be targeted. We recommend that biochemical measures of exposure are used in conjunction with self-reporting.
Self-reported ETSE was strongly associated with reduced gestational age at delivery, a relationship which has previously been debated. 5, 6 Although this mean reduction (0.2 weeks) is small at an individual level, at a population level this may shift the distribution to the left resulting in a significant burden; further, active maternal smoking only reduced gestation by 0.6 weeks on average and yet more than doubled the rate of PTB. The deleterious effect of ETSE on perinatal outcomes is also emphasized by the finding of a strong association with reduced birth weight of a similar magnitude to that previously reported. 5, 6, 16 Our study shows that ETSE is associated with both shorter gestation and reduced birth weight, but it was not associated with an increased risk of either SGA or PTB. A larger number of participants may be required to study the associations of ETSE with noncontinuous, rarer outcomes such as PTB and SGA.
Conclusions
Pregnant women reporting household exposure to environmental tobacco smoke deliver their babies at earlier gestations and with lower birth weights when compared to unexposed women. The value of eCO as an objective measure of exposure and in quantifying the risk of adverse perinatal outcomes remains to be determined. This information is important in advising women and their families and further supports public health efforts to reduce exposure to tobacco smoke.
